Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients

…, H de Jager, D Weiskopf, PHM van der Kuy… - Science …, 2022 - science.org
The severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …

[HTML][HTML] Immunogenicity and reactogenicity of vaccine boosters after Ad26. COV2. S priming

…, RD de Vries, PHM van der Kuy - … England Journal of …, 2022 - Mass Medical Soc
Background The Ad26.COV2.S vaccine, which was approved as a single-shot immunization
regimen, has been shown to be effective against severe coronavirus disease 2019. …

Patient selection criteria for outpatient joint arthroplasty

NP Kort, YFL Bemelmans, PHM van der Kuy… - Knee Surgery, Sports …, 2017 - Springer
Purpose General consensus of patient selection criteria for outpatient joint arthroplasty is
lacking, which is paramount to prevent prolonged hospital stay, adverse events and/or …

[HTML][HTML] Immunogenicity of bivalent omicron (BA. 1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON) …

…, RD de Vries, PHM van der Kuy - The Lancet Infectious …, 2023 - thelancet.com
… /M group, and 1·16 [1·13–1·19] for the mRNA/MP and mRNA/P groups (p=0·51). The GMR
appeared to be higher in the Ad/M group than in the mRNA/M group, but was not significant (p

No advantage of adrenaline in the local infiltration analgesia mixture during total knee arthroplasty

…, YFL Bemelmans, PHM van der Kuy… - Knee Surgery, Sports …, 2017 - Springer
Purpose Local infiltration analgesia (LIA) is widely applied in patients undergoing total knee
arthroplasty (TKA). In daily practice, adrenaline is added to the LIA mixture to achieve …

[HTML][HTML] Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA. 1 and BA. 5 boosters

…, MPG Koopmans, PHM van der Kuy… - Nature …, 2024 - nature.com
Waning antibody responses after COVID-19 vaccination combined with the emergence of the
SARS-CoV-2 Omicron lineage led to reduced vaccine effectiveness. As a countermeasure, …

[HTML][HTML] Heterologous Ad26. COV2. S prime and mRNA-based boost COVID-19 vaccination regimens: the SWITCH trial protocol

…, NA Kootstra, WJR Rietdijk, PHM van der Kuy - Frontiers in …, 2021 - frontiersin.org
… Copyright © 2021 Sablerolles, Goorhuis, GeurtsvanKessel, de Vries, Huckriede, Koopmans,
Lafeber, Postma, van Baarle, Visser, Dalm, Kootstra, Rietdijk and van der Kuy. This is an …

Long QTc interval and torsade de pointes caused by fluconazole

…, PHM van der Kuy, WNKA van Mook - Annals of …, 2006 - journals.sagepub.com
Objective: To describe a patient who developed torsade de pointes while being treated with
fluconazole. Case Summary: A 33-year-old woman with a 5 year history of systemic lupus …

Durability of immune responses after boosting in Ad26. COV2. S-primed healthcare workers

…, RD De Vries, PHM Van Der Kuy… - Clinical Infectious …, 2023 - academic.oup.com
The emergence of SARS-CoV-2 variants raised questions regarding the durability of immune
responses after homologous or heterologous boosters after Ad26.COV2.S-priming. We …

[PDF][PDF] Ad26. COV2. S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination

…, RL de Swart, MPG Koopmans, PHM van der Kuy… - Iscience, 2023 - cell.com
The emergence of novel SARS-CoV-2 variants led to the recommendation of booster
vaccinations after Ad26.COV2.S priming. It was previously shown that heterologous booster …